Allenyl Azide Cycloaddition Chemistry
3-(2-Acetyl-phenyl)-pyrrolidin-2-one (25). A deoxygenated sol-
ution of allenylazide 20a (30 mg, 0.15 mmol) in toluene-d8, (2 mL)
was heated in a sealed tube at 100 °C for 5 h. The reaction mixture
was cooled to room temperature and solvent evaporated to give a
brown film. Purification of this crude oil by flash chromatography
(9:1 EtOAc/Et3N) resulted in 25 as a yellow film (19 mg, 62%).
(m, 1H), 1.69 (bs, 1H), 1.52 (d, J ) 7.1 Hz, 3H), 1.41 (t, J ) 7.1
Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 166.8, 148.5, 144.5, 130.8,
129.9, 125.8, 123.9, 122.8, 68.3, 61.5, 55.1, 47.6, 46.6, 31.1, 14.8,
12.5; APCIMS m/z relative intensity 271 (MH+ 100); HRMS
(+APCI) calcd for C16H19N2O2 271.1423, found 271.1441.
Furanyl Substrate 26. To a solution of propargyl azidomesylate
19 (0.14 g, 0.65 mmol) and Pd(PPh3)4 (36 mg, 0.03 mmol, 5 mol%)
in 10 mL of THF were added commercially available 3-furanyl
boronic acid (0.17 g, 1.5 mmol) and sodium carbonate (95 mg, 0.9
mmol). After the reaction mixture was refluxed for 4 h, the solution
was poured into water and the mixture was extracted with 15 mL
of Et2O. Drying over Na2SO4, followed by evaporation of solvent
and chromatography on silica gel using 5% Et2O in hexane afforded
1
IR (neat) 3297, 1684 cm-1; H NMR (400 MHz, CDCl3) δ 7.73
(d, J ) 7.7 Hz, 1H) 7.49 (t, J ) 6.4 Hz, 1H), 7.36 (q, J ) 7.7 Hz,
2H), 4.31 (t, J ) 9.4 Hz, 1H), 3.49 (dd, J ) 8.9, 4.8 Hz, 2H), 2.77
(m, 1H), 2.63 (s, 3H) 2.22 (m 1H); 13C NMR (75 MHz, CDCl3) δ
202.6, 179.1, 139.2, 139.0, 132.5, 130.3, 129.6, 127.3, 45.6, 40.8,
32.0, 30.0; APCIMS m/z relative intensity 204 (MH+ 40); HRMS
(+APCI) calcd for C12H14NO2 204.1025, found 204.1033.
Phenyl Substrate (23a). Following General Procedure 2, azi-
doallene 20a (45 mg, 0.23 mmol) was converted into cyanopyr-
26 as a pale yellow oil (35 mg, 28%). IR (neat) 2098, 1948 cm-1
;
1H NMR (400 MHz, CDCl3) δ 7.38 (t, J ) 1.8 Hz, 1H), 7.37 (s,
1H), 6.4(d, J ) 1.73 Hz, 1H), 5.42 (m, 1H), 3.40 (t, J ) 6.9 Hz,
2H), 2.37 (q, J ) 6.6 Hz, 2H), 2.01 (d, J ) 2.9 Hz, 3H); 13C NMR
(75 MHz, CDCl3) δ 204.4, 143.7, 138.8, 124.9, 109.4, 95.3, 89.3,
51.1, 29.0, 17.6; TOFMSES m/z relative intensity (MH+ 20); HRMS
(+ESMS) calcd for C10H12N3O 190.0980, found 190.0987.
Furanyl Cyanopyrrolidine 28. Following General Procedure
2, azidoallene 26 (30 mg, 0.16 mmol) was converted into cyan-
opyrrolidine 28 (8 mg, 27%). IR (neat) 3346, 2098 cm-1; 1H NMR
(400 MHz, CDCl3) δ 7.34 (d, J ) 1.0 Hz, 1H), 6.2 (d, J ) 1.8 Hz,
1H), 3.97 (dd, J ) 8.4, 4.0 Hz, 1H), 3.46 (q, J ) 7.1, 1H), 3.22
(m, 1H), 3.11-3.18 (m, 1H), 2.16-2.24 (m, 1H), 1.93-2.04 (m,
1H), 1.34 (d, 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 157.3,
147.6, 127.0, 123.0, 107.6, 72.6, 50.7, 48.0, 41.6, 29.2, 13.6;
TOFMSES m/z relative intensity 189 (MH+ 100); HRMS (+ES)
calcd for C11H13N2O 189.1028, found 189.1019.
1
rolidine 23a (23 mg, 50%). IR (neat) 3342, 2097 cm-1; H NMR
(400 MHz, CDCl3) δ 7.29-7.27 (m, 2H), 7.14-7.19 (m, 2H), 4.05
(dd, J ) 8.7, 2.7 Hz, 1H), 3.64 (q, J ) 7.2 Hz, 1H), 3.24 (apparent
q, J ) 7.3 Hz, 1H), 3.12-3.07 (m, 1H), 2.56-2.48 (m, 1H),
2.15-2.07 (m 1H), 1.51 (d, J ) 7.1 Hz, 3H); 13C NMR (75 MHz,
CDCl3) δ 144.0, 143.2, 128.2, 128.1, 124.4, 124.0, 123.2, 68.3,
55.5, 47.5, 46.7, 31.3, 12.5; APCIMS m/z relative intensity 199
(MH+ 100); HRMS (+APCI) calcd for C13H14N2 199.1241, found
199.1229.
Methoxyphenyl Substrate (23b). Following General Procedure
2, azidoallene 20b (70 mg, 0.31 mmol) was converted into cyano-
pyrrolidine 23b (36 mg, 52%). IR (neat) 3441, 2220 cm-1; 1H NMR
(400 MHz, CDCl3) δ 7.04 (d, J ) 8.3 Hz, 1H), 6.81 (dd, J ) 8.9,
1.9 Hz, 1H), 6.70 (s, 1H), 3.99 (dd, J ) 6.7, 2.2 Hz, 1H), 3.81 (s,
3H), 3.59 (q, J ) 7.1, 1H), 3.24 (apparent q, J ) 9.2 Hz, 1H), 3.12
(ddd, J ) 8.3, 8.3, 4.3 Hz, 1H), 2.53-2.45 (m, 1H), 2.13-2.06
(m, 1H), 1.76 (bs, 1H), 1.47 (d, 7.1 Hz, 3H); 13C NMR (75 MHz,
CDCl3) δ 160.3, 145.5, 135.3, 124.6, 123.2, 113.8, 110.0, 68.5,
55.9, 55.4, 46.8, 31.1, 12.8; APCIMS m/z relative intensity 229
(MH+ 100); HRMS (+APCI) calcd for C14H17N2O 229.1335, found
229.1335.
1-Azido-6-methylhepta-3,4,7-triene (30a). Following General
Procedure 1, azidomesylate 19 (200 mg, 0.92 mmol) was converted
into azidoallene 30a (105 mg, 76%). IR (neat) 2097, 1948 cm-1
;
1H NMR (360 MHz, CDCl3) δ 6.25 (dd, J ) 17.4, 10.6 Hz, 1H)
5.16 (m, 1H), 5.04 (d, J ) 17.4 Hz, 1H), 4.96 (d, J ) 10.6 Hz,
1H), 3.26 (t, J ) 6.9 Hz, 2H), 2.22 (q, J ) 6.7 Hz, 2H), 1.75 (d,
J ) 2.7 Hz, 3H); 13C NMR (90 MHz, CDCl3) δ 207.9, 136.0, 113.0,
101.9, 87.2, 51.0, 28.8, 15.1; APCIMS m/z relative intensity 244
(MH+-N2 100); HRMS (+ESI) calcd for C16H23N6 (M2H+)
299.1984, found 299.1976.
Methylphenyl Substrate (23c). Following General Procedure
2, azidoallene 20c (35 mg, 0.16 mmol) was converted into
cyanopyrrolidine 23c (22 mg, 63%). IR (neat) 3337, 2220 cm-1
;
1H NMR (400 MHz, CDCl3) δ 7.09 (d, J ) 7.7 Hz, 1H), 7.02 (d,
J ) 7.7 Hz, 1H), 6.98 (s, 1H), 4.01 (dd, J ) 8.7, 2.4 Hz, 1H), 3.60
(q, J ) 7.0 Hz, 1H), 3.25 (apparent q, J ) 8.5 Hz, 1H), 3.10 (ddd,
J ) 8.0, 8.0, 3.6 Hz, 1H), 2.45-2.53 (m, 1H), 2.36 (s, 3H),
2.06-2.13 (m, 1H), 1.85 (bs, 1H), 1.48 (d, J ) 7.1 Hz, 3H); 13C
NMR (75 MHz, CDCl3) δ 144.1, 140.2, 138.1, 128.9, 125.1, 123.7,
123.9, 68.4, 55.4, 47.1, 46.7, 31.1, 21.7, 12.6; APCIMS m/z relative
intensity 213 (MH+ 100); HRMS (+APCI) calcd for C14H17N2
213.1381, found 213.1386.
(E)-1-Azido-6-methyl-8-(phenyl)octa-3,4,7-triene (30b). To a
solution of propargyl azidomesylate 19 (55 mg, 0.25 mmol) and
Pd(PPh3)4 (15 mg, 0.01, 5 mol%) in 10 mL of THF were added
commercially available trans-2-phenylvinylboronic acid (67 mg,
0.45 mmol) and sodium carbonate (95 mg, 0.9 mmol). After the
reaction mixture was refluxed for 4 h, the solution was poured into
water and the mixture was extracted with 15 mL of Et2O. Drying
over Na2SO4, followed by evaporation of solvent and chromatog-
raphy on silica gel using 5% Et2O in hexane afforded 30b as a
pale yellow oil (33 mg, 59%). IR (neat) 2096, 1942 cm-1; 1H NMR
(360 MHz, CDCl3) δ 7.11-7.38 (m, 5H), 6.68 (d, J ) 16.1 Hz,
1H), 6.35 (d, J ) 16.4 Hz, 1H), 5.24 (bs, 1H), 3.29 (t, J ) 6.7 Hz,
2H), 2.76 (q, J ) 6.7 Hz, 2H), 1.87 (d, J ) 2.1 Hz, 3H); 13C NMR
(90 MHz, CDCl3) δ 208.9, 137.9, 129.0, 128.1, 128.0, 127.7, 126.7,
102.3, 87.4, 51.3, 29.0, 15.9; APCIMS m/z relative intensity 198
(MH+ - N2 100); HRMS (+ESI) calcd for C14H16N 198.1283,
found 198.1292.
Chlorophenyl Substrate (23d). Following General Procedure
2, azidoallene 20d (35 mg, 0.15 mmol) was converted into
cyanopyrrolidine 23d (16 mg, 47%). Crystals suitable for X-ray
crystallographic analysis were obtained by slow evaporation of an
Et2O solution of 23d over a period of 48 h at 25 °C. Mp: 92-98
1
°C. IR (neat) 3338, 2220 cm-1; H NMR (400 MHz, CDCl3) δ
7.24 (dd, J ) 8.1, 1.3 Hz, 1H), 7.15 (s, 1H), 7.06 (d, J ) 8.1 Hz,
1H), 4.01 (dd, J ) 8.9, 2.7 Hz, 1H), 3.58 (q, J ) 7.0 Hz, 1H), 3.24
(apparent q, J ) 8.3 Hz, 1H), 3.12 (ddd, J ) 8.1, 8.1, 4.3 Hz, 1H),
2.55-2.47 (m, 1H), 2.12-2.04 (m, 1H), 1.88 (bs, 1H), 1.48 (d, J
) 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 146.0, 141.7, 133.9,
128.4, 125.2, 124.8, 122.8, 68.4, 55.1, 47.1, 46.6, 31.1, 12.5;
APCIMS m/z relative intensity 233 (MH+ 100); HRMS (+APCI)
calcd for C13H14N2Cl 233.0845, found 233.0840.
Ethyl (E)-1-Azido-4-(methyl)oct-2,4,5-trienoate (30c). To a
solution of propargyl azidomesylate 19 (108 mg, 0.50 mmol) and
Pd(PPh3)4 (30 mg, 0.02, 5 mol%) in 10 mL of THF was added
(Z)-ethoxycarbonylethenylzinc iodide20 (1.5 mmol), and the mixture
was heated at 50 °C for 3 h. After the reaction solution was cooled
to room temperature, water was added and the mixture was extracted
with 15 mL of Et2O. The organic layer was dried over Na2SO4
and solvent was evaporated in vacuo. The crude product was
purified by chromatography using 8% Et2O in hexane as the eluant
to give 30c as a yellow oil (35 mg, 32%). IR (neat) 2099, 1941
Phenylester Substrate (23e). Following General Procedure 2,
azidoallene 20e (30 mg, 0.11 mmol) was converted into cyanopy-
rrolidine 23e (11 mg, 37%). IR (neat) 3339, 2225, 1714 cm-1; 1H
NMR (400 MHz, CDCl3) δ 7.98 (d, J ) 7.9 Hz, 1H), 7.85 (s, 1H),
7.20 (d, J ) 7.9 Hz, 1H), 4.38 (q, J ) 7.1 Hz, 2H), 4.06 (dd, J )
8.7, 2.5 Hz, 1H), 3.65 (q, J ) 6.9 Hz, 1H), 3.27 (apparent q, J )
8.5 Hz, 1H), 3.14-3.07 (m, 1H), 2.60-2.51 (m, 1H), 2.20-2.12
1
cm-1; H NMR (400 MHz, CDCl3) δ 7.32 (d, J ) 15.7 Hz, 1H),
5.83 (d, J ) 15.7 Hz, 1H), 5.38 (bs, 1H), 4.22 (q, J ) 7.2 Hz, 2H),
J. Org. Chem. Vol. 73, No. 13, 2008 5097